The Nurse as Principal Investigator in a Pharmaceutically Sponsored Drug Trial: Considerations and Challenges

Margaret  Rosenzweig

doi:10.1188/05.ONF.293-299

We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.

The Nurse as Principal Investigator in a Pharmaceutically Sponsored Drug Trial: Considerations and Challenges

Margaret Rosenzweig

Catherine M. Bender

 Adam M Brufsky

ONF 2005, 32(2), 293-299. DOI: 10.1188/05.ONF.293-299

Preview

Purpose/Objectives: To discuss the process, considerations, benefits, and challenges of the nurse as principal investigator in a cancer care drug trial.

Members Only

Not a current ONS member or journal subscriber?

Become a Member

Explore the benefits of membership.

Join ONS or Renew Membership

Purchase This Article

Receive a PDF to download and print.